OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
Mi Hee Park, Miran Jo, Yu Ri Kim, et al.
Pharmacology & Therapeutics (2016) Vol. 163, pp. 1-23
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases
Mehdi Sharifi‐Rad, N. V. Anil Kumar, Paolo Zucca, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 1489

Oxidative stress in autoimmune rheumatic diseases
Miranda J. Smallwood, Ahuva Nissim, Annie R. Knight, et al.
Free Radical Biology and Medicine (2018) Vol. 125, pp. 3-14
Open Access | Times Cited: 278

Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
Barbara Marengo, Mariapaola Nitti, Anna Lisa Furfaro, et al.
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 269

A role for 2-Cys peroxiredoxins in facilitating cytosolic protein thiol oxidation
Sarah Stöcker, Michael Maurer, Thomas Ruppert, et al.
Nature Chemical Biology (2017) Vol. 14, Iss. 2, pp. 148-155
Open Access | Times Cited: 183

Overview of the Antioxidant and Anti-Inflammatory Activities of Selected Plant Compounds and Their Metal Ions Complexes
Paulina Mucha, Anna Skoczyńska, Magdalena Małecka, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4886-4886
Open Access | Times Cited: 138

Redox signaling at the crossroads of human health and disease
Jing Zuo, Zhe Zhang, Maochao Luo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 77

The role of peroxiredoxins in cancer
Arianna Nicolussi, Sonia D'inzeo, Carlo Capalbo, et al.
Molecular and Clinical Oncology (2017) Vol. 6, Iss. 2, pp. 139-153
Open Access | Times Cited: 164

Peroxiredoxin 2 activates microglia by interacting with Toll-like receptor 4 after subarachnoid hemorrhage
Yue Lu, Xiangsheng Zhang, Zihuan Zhang, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 113

The Role of Peroxiredoxin 6 in Cell Signaling
José A. Arevalo, José Pablo Vázquez‐Medina
Antioxidants (2018) Vol. 7, Iss. 12, pp. 172-172
Open Access | Times Cited: 87

Catalysis of Peroxide Reduction by Fast Reacting Protein Thiols
Ari Zeida, Madia Trujillo, Gerardo Ferrer‐Sueta, et al.
Chemical Reviews (2019) Vol. 119, Iss. 19, pp. 10829-10855
Closed Access | Times Cited: 86

DHA and Its Elaborated Modulation of Antioxidant Defenses of the Brain: Implications in Aging and AD Neurodegeneration
Mario Dı́az, Fátima Mesa-Herrera, Raquel Marín
Antioxidants (2021) Vol. 10, Iss. 6, pp. 907-907
Open Access | Times Cited: 56

High-Dose Vitamin C for Cancer Therapy
Ali Mussa, Ros Akmal Mohd Idris, Naveed Ahmed, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 711-711
Open Access | Times Cited: 51

Redox signaling and metabolism in Alzheimer's disease
Mariana Holubiec, Manuela Gellert, Eva-Maria Hanschmann
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 39

New insights into the roles of peroxiredoxins in cancer
Yan Liu, Pu Wang, Weina Hu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114896-114896
Open Access | Times Cited: 27

Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy
Ying Hou, Heng Wang, Jiarui Wu, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1566-1595
Closed Access | Times Cited: 10

Implications and progression of peroxiredoxin 2 (PRDX2) in various human diseases
Priyanka Balasubramanian, Varshini Vijayarangam, Mangayer karasi Gopalakrishnan Deviparasakthi, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155080-155080
Closed Access | Times Cited: 8

PRDX2 induces tumor immune evasion by modulating the HDAC3-Galectin-9 axis in lung adenocarcinoma cells
Yunjia Dong, Anqi Cheng, Jiawei Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Prdx1 alleviates cardiomyocyte apoptosis through ROS-activated MAPK pathway during myocardial ischemia/reperfusion injury
Wanwan Guo, Xiaojuan Liu, Jingjing Li, et al.
International Journal of Biological Macromolecules (2018) Vol. 112, pp. 608-615
Closed Access | Times Cited: 81

Hyperoxidation of Peroxiredoxins: Gain or Loss of Function?
Elizabeth A. Veal, Zoe Underwood, Lewis Tomalin, et al.
Antioxidants and Redox Signaling (2017) Vol. 28, Iss. 7, pp. 574-590
Closed Access | Times Cited: 71

Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy
Yueming Zhu, Angela E. Dean, Nobuo Horikoshi, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 9, pp. 3682-3691
Open Access | Times Cited: 68

Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins
Jesalyn Bolduc, Kimberly Nelson, Alexina C. Haynes, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 30, pp. 11901-11912
Open Access | Times Cited: 67

S-nitrosylation of the Peroxiredoxin-2 promotes S-nitrosoglutathione-mediated lung cancer cells apoptosis via AMPK-SIRT1 pathway
Yihan Zhang, Changning Sun, Guokai Xiao, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 5
Open Access | Times Cited: 62

Circulating Peroxiredoxin-1 is a novel damage-associated molecular pattern and aggravates acute liver injury via promoting inflammation
Ying He, Shenglan Li, Damu Tang, et al.
Free Radical Biology and Medicine (2019) Vol. 137, pp. 24-36
Closed Access | Times Cited: 61

Catalase expression is an independent prognostic marker in liver hepatocellular carcinoma
Yu‐Chia Chen, Hsin‐Hung Chen, Po‐Ming Chen
ONCOLOGIE (2024) Vol. 26, Iss. 1, pp. 79-90
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top